Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Ptc Therapeutics (PTCT) over the last 9 years, with Q3 2025 value amounting to $18.5 million.

  • Ptc Therapeutics' Change in Inventory rose 49645.85% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 167785.43%. This contributed to the annual value of -$6.2 million for FY2024, which is 17532.69% down from last year.
  • Latest data reveals that Ptc Therapeutics reported Change in Inventory of $18.5 million as of Q3 2025, which was up 49645.85% from $10.8 million recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Change in Inventory peaked at $18.5 million during Q3 2025, and registered a low of -$11.1 million during Q4 2024.
  • For the 5-year period, Ptc Therapeutics' Change in Inventory averaged around $1.8 million, with its median value being $676000.0 (2021).
  • Its Change in Inventory has fluctuated over the past 5 years, first tumbled by 182450.98% in 2021, then skyrocketed by 150464.4% in 2023.
  • Ptc Therapeutics' Change in Inventory (Quarter) stood at $676000.0 in 2021, then surged by 772.78% to $5.9 million in 2022, then tumbled by 200.64% to -$5.9 million in 2023, then tumbled by 86.7% to -$11.1 million in 2024, then surged by 267.11% to $18.5 million in 2025.
  • Its Change in Inventory was $18.5 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$2.2 million in Q1 2025.